Acquisition by Alexander Zukiwski of 3000 shares of Casi Pharmaceuticals subject to Rule 16b-3

CASI
 Stock
  

USD 1.99  0.08  4.19%   

Casi Pharmaceuticals investor sentiment overview provides quick insight into current market opportunities from investing in Casi Pharmaceuticals. The current market sentiment together Casi Pharmaceuticals' historical and current headlines can help investors to time the market. Many technical investors use Casi Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Continue to Casi Pharmaceuticals Hype Analysis, Casi Pharmaceuticals Correlation and Casi Pharmaceuticals Performance.
  
Casi Pharmaceuticals stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Casi Pharmaceuticals daily returns and investor perception about the current pice of Casi Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Filed transaction by Casi Pharmaceuticals Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Casi Pharmaceuticals insider trading alert for grant of employee stock option (right to buy) by Alexander Zukiwski, EVP and Chief Medical Officer, on 9th of September 2022. This event was filed by Casi Pharmaceuticals Inc with SEC on 2022-09-09. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Casi Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Casi Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Casi Pharmaceuticals Investor Sentiment by Other News Outlets

Casi Pharmaceuticals Fundamental Analysis

We analyze Casi Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Casi Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Casi Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned by Institutions

Shares Owned by Institutions Comparative Analysis

Casi Pharmaceuticals is currently under evaluation in shares owned by institutions category among related companies. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Casi Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Casi Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Casi Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Casi Pharmaceuticals by comparing valuation metrics with similar companies.
Continue to Casi Pharmaceuticals Hype Analysis, Casi Pharmaceuticals Correlation and Casi Pharmaceuticals Performance. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for analysis

When running Casi Pharmaceuticals price analysis, check to measure Casi Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Casi Pharmaceuticals is operating at the current time. Most of Casi Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Casi Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Casi Pharmaceuticals' price. Additionally, you may evaluate how the addition of Casi Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Casi Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Casi Pharmaceuticals. If investors know Casi Pharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Casi Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
26.3 M
Quarterly Revenue Growth YOY
0.26
Return On Assets
(0.15) 
Return On Equity
(0.27) 
The market value of Casi Pharmaceuticals is measured differently than its book value, which is the value of Casi Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Casi Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Casi Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Casi Pharmaceuticals' market value can be influenced by many factors that don't directly affect Casi Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Casi Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Casi Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Casi Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.